Survival of patients with hepatopulmonary syndrome related to cirrhotic and non-cirrhotic (schistosomiasis) portal hypertension

Table 1 Sociodemographic and clinical characteristics according to the occurrence of death in 113 patients with hepatosplenic schistosomiasis, with and without hepatopulmonary syndrome, reassessed after 10 years, Recife, 2024, n (%)

Characteristics	Death		OR	95%CI	P value
	Yes	No
Age (years), mean ± SD	63.86 ± 9.97	61.83 ± 12.43	1.02	0.98-1.05	0.336
Age group
Up to 49	5 (35.7)	9 (64.3)	1.00	-	-
50-59	14 (63.6)	8 (36.4)	3.15	0.78-12.73	0.107
60-69	30 (61.2)	19 (38.8)	2.84	0.83-9.77	0.097
70-79	12 (52.2)	11 (47.8)	1.96	0.50-7.69	0.333
80 or more	4 (80.0)	1 (20.0)	7.20	0.62-83.34	0.114
Sex
Female	26 (54.2)	22 (45.8)	1.00	-	-
Male	39 (60.0)	26 (40.0)	1.27	0.60-2.70	0.535
Etiology of liver disease
HSS	25 (50.0)	25 (50.0)	1.00	-	-
HSS/cirrhosis	40 (63.5)	23 (36.5)	1.74	0.82-3.70	0.151
Hepatopulmonary syndrome
No	46 (62.2)	28 (37.8)	1.00	-	-
Yes	19 (48.7)	20(51.3)	0.58	0.26-1.27	0.171

OR: Odds ratio; CI: Confidence interval; HSS: Hepatosplenic schistosomiasis.

Table 2 Interval (years) to death for the 65 patients with a death record, according to the presence or absence of hepatopulmonary syndrome after 10 years, Recife, 2024

Hepatopulmonary syndrome	n	Minimum	Maximun	Average (years)	Deviation	P value
No	46	0.10	12.64	5.65	4.08	-
Yes	19	0.20	10.89	3.37	3.04	0.01741

¹Student’s t-test.